Traversa U, de Angelis L, Vertua R
Naunyn Schmiedebergs Arch Pharmacol. 1976 Aug;294(2):109-13. doi: 10.1007/BF00507842.
The tissue distribution of radioactivity after oral administration to rats of 14C-heteronium bromide is measured by liquid scintillation counting and the results expressed as specific activity and percentage of administered radioactivity. From the data obtained in blood, liver, kidney. stomach, duodenum, cecum, large intestine and stool some conclusions can be drawn. Heteronium bromide undergoes a rapid systemic absorption, the radioactivity being present as early as 15 min from the administration, in all the tested organs. The blood levels show two peaks: one at 120 min and a second at 360 min. This diphasic behaviour can be explained either by the presence of an active enterohepatic circulation, as indirectly indicated by the data from liver and duodenum, or by a transient shift of the molecule from blood to other tissues, rich in polysulfuronic acids. The principal route of excretion is represented by the kidney, where consistent levels are reached at 120 min, while the intestinal route becomes evident at 240 min and reaches its maximum at 720 min. The complete metabolic cycle of the compound is long lasting, since in all the tested tissues, marked radioactivity levels are still present after 720 min. The pharmacokinetic profile obtained, suggesting a long persistence of the drug and/or of its metabolites in the organism, is in agreement with previous pharmacodynamic data showing a long lasting action for heteronium bromide.
通过液体闪烁计数法测定大鼠口服14C - 溴化海托铵后放射性的组织分布情况,结果以比活度和给药放射性的百分比表示。根据在血液、肝脏、肾脏、胃、十二指肠、盲肠、大肠和粪便中获得的数据可以得出一些结论。溴化海托铵可迅速被全身吸收,给药后15分钟,在所有测试器官中就已出现放射性。血药浓度呈现两个峰值:一个在120分钟,另一个在360分钟。这种双相行为可以通过肝肠循环活跃来解释,这从肝脏和十二指肠的数据中可间接表明,或者是分子从血液短暂转移到富含聚磺酸的其他组织中。主要排泄途径是通过肾脏,在120分钟时达到稳定水平,而肠道途径在240分钟时开始明显,并在720分钟时达到最大值。该化合物的完整代谢周期持续时间长,因为在所有测试组织中,720分钟后仍存在明显的放射性水平。所获得的药代动力学特征表明该药物和/或其代谢产物在生物体内持续存在时间长,这与之前显示溴化海托铵具有持久作用的药效学数据一致。